Switching from insulin to oral sulfonylureas in patients with diabetes due to Kir6.2 mutations

Article Abstract:

The glycemic control in patients with Kir6.2 mutations who received appropriate doses of sulfonylureas are assessed and the mechanism of insulin dependence in patients who are able to switch from insulin to oral sulfonylurea therapy are examined. The results have shown that sulfonylurea therapy is safe in the short term for patients with diabetes caused by KCNJ11 mutations and is probably more effective than insulin therapy.

Author: Ashcroft, Frances M., Pearson, Eawn R., Flechter, Isabelle, Njolstad, Pal R., Malecki, Maciej T., Flanagan, Sarah E., Larkin, Brian, Klimes, Iwar, Shield, Julian, Codner, Ethel, Iotova, Violeta; Slingerland, Annabelle S., Robert, Jean-Jacques; Holst, Jens J., Clark, Penny M.; Ellard, Sian, Sovik, Oddmund; Polak, Michel; Hattersley, Andrew T.
Care and treatment, Blood sugar, Blood glucose, Control, Insulin, Sulfonylurea compounds, Sulfonylureas, Hypoglycemic sulfonylureas

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Inhaled insulin for diabetes mellitus

Article Abstract:

A case study of a 52-year-old man with an 8-year history of diabetes mellitus is referred to an endocrinologist for evaluation of his benefit from inhaled insulin. The clinical use of the therapy, potential adverse effects and relevant formal guidelines are presented, and clinical recommendations are provided for this specific patient.

Author: Arky, Ronald A., McMohan, Graham T.
United States, Case studies, Diabetes, Diabetes mellitus, Inhaled medication, Clinical report

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA



Subjects list: Health aspects
This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.